Search research articles
Contact Us
Filters
Showing results (581-590 of 750) with videos related to
Page
of 75
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 15, 2008
HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005
Kate Buchacz, Jeffrey D Klausner, Peter R Kerndt, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 21, 2018
Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD
Nagarajan Muthukaman, Sanjay Deshmukh, Shital Tondlekar, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2016
Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2',3':3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E<sub>2</sub> synthase-1 (mPGES-1) inhibitor
Nagarajan Muthukaman, Sanjay Deshmukh, Neelam Sarode, et al.
Biochimica Et Biophysica Acta. General Subjects
|
March 17, 2020
Transgenic models for investigating the nervous system: Currently available neurofluorescent reporters and potential neuronal markers
Michael Yamakawa, Samuel M Santosa, Neeraj Chawla, et al.
European Journal of Medicinal Chemistry
|
March 15, 2025
A new potent and selective peroxisome proliferator-activated receptor alpha partial agonist displays anti-steatotic effects In vitro and behaves as a safe hypolipidemic and hypoglycemic agent in a diabetic mouse model
Antonio Laghezza, Emanuele Falbo, Federica Gilardi, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 21, 2022
Design and synthesis of novel spirocyclic carboxylic acids as potent and orally bioavailable DGAT1 inhibitors and their biological evaluation
Summon Koul, Suresh Kurhade, Sandeep Bhosale, et al.
Molecular Oncology
|
September 21, 2025
Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemia
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, et al.
Science (New York, N.Y.)
|
October 26, 2013
Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons
Daniel F Tardiff, Nathan T Jui, Vikram Khurana, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 13, 2017
Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E<sub>2</sub> synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model
Nagarajan Muthukaman, Macchindra Tambe, Mahamadhanif Shaikh, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
May 9, 2015
High-throughput screening for modulators of cellular contractile force
Chan Young Park, Enhua H Zhou, Dhananjay Tambe, et al.
Page
of 75
Search research articles
Search
Showing results (581-590 of 750) with videos related to
Sort By:
Page
of 75
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 15, 2008
HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005
Kate Buchacz, Jeffrey D Klausner, Peter R Kerndt, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 21, 2018
Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD
Nagarajan Muthukaman, Sanjay Deshmukh, Shital Tondlekar, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2016
Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2',3':3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E<sub>2</sub> synthase-1 (mPGES-1) inhibitor
Nagarajan Muthukaman, Sanjay Deshmukh, Neelam Sarode, et al.
Biochimica Et Biophysica Acta. General Subjects
|
March 17, 2020
Transgenic models for investigating the nervous system: Currently available neurofluorescent reporters and potential neuronal markers
Michael Yamakawa, Samuel M Santosa, Neeraj Chawla, et al.
European Journal of Medicinal Chemistry
|
March 15, 2025
A new potent and selective peroxisome proliferator-activated receptor alpha partial agonist displays anti-steatotic effects In vitro and behaves as a safe hypolipidemic and hypoglycemic agent in a diabetic mouse model
Antonio Laghezza, Emanuele Falbo, Federica Gilardi, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 21, 2022
Design and synthesis of novel spirocyclic carboxylic acids as potent and orally bioavailable DGAT1 inhibitors and their biological evaluation
Summon Koul, Suresh Kurhade, Sandeep Bhosale, et al.
Molecular Oncology
|
September 21, 2025
Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemia
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, et al.
Science (New York, N.Y.)
|
October 26, 2013
Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons
Daniel F Tardiff, Nathan T Jui, Vikram Khurana, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 13, 2017
Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E<sub>2</sub> synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model
Nagarajan Muthukaman, Macchindra Tambe, Mahamadhanif Shaikh, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
May 9, 2015
High-throughput screening for modulators of cellular contractile force
Chan Young Park, Enhua H Zhou, Dhananjay Tambe, et al.
Page
of 75